BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35871906)

  • 1. Mode of Detection of Second Events in Routine Surveillance of Early Stage Breast Cancer Patients.
    Tun SM; Alluri S; Rastegar V; Visintainer P; Mertens W; Makari-Judson G
    Clin Breast Cancer; 2022 Oct; 22(7):e818-e824. PubMed ID: 35871906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.
    Robertson C; Arcot Ragupathy SK; Boachie C; Dixon JM; Fraser C; Hernández R; Heys S; Jack W; Kerr GR; Lawrence G; MacLennan G; Maxwell A; McGregor J; Mowatt G; Pinder S; Ternent L; Thomas RE; Vale L; Wilson R; Zhu S; Gilbert FJ
    Health Technol Assess; 2011 Sep; 15(34):v-vi, 1-322. PubMed ID: 21951942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Tanaka-Akashi S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Breast Cancer; 2005; 12(2):104-11. PubMed ID: 15858440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer.
    Dalberg K; Mattsson A; Sandelin K; Rutqvist LE
    Breast Cancer Res Treat; 1998 May; 49(1):69-78. PubMed ID: 9694613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local recurrence risk after previous salvage mastectomy.
    Tanabe M; Iwase T; Okumura Y; Yoshida A; Masuda N; Nakatsukasa K; Shien T; Tanaka S; Komoike Y; Taguchi T; Arima N; Nishimura R; Inaji H; Ishitobi M;
    Eur J Surg Oncol; 2016 Jul; 42(7):980-5. PubMed ID: 27055945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional Recurrence Patterns in Patients With Different Molecular Subtypes of Breast Cancer.
    Cheun JH; Kim HK; Moon HG; Han W; Lee HB
    JAMA Surg; 2023 Aug; 158(8):841-852. PubMed ID: 37342035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics and prognosis of patients with ipsilateral breast tumor recurrence after breast conservation therapy].
    Sun GY; Wang SL; Tang Y; Jin J; Song YW; Liu YP; Wang WH; Fang H; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):352-358. PubMed ID: 29860762
    [No Abstract]   [Full Text] [Related]  

  • 11. Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation.
    Alpert TE; Kuerer HM; Arthur DW; Lannin DR; Haffty BG
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):845-51. PubMed ID: 16199315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of appropriate short-term mammographic surveillance in patients who undergo breast-conserving Surgery (BCS).
    Gunia SR; Merrigan TL; Poulton TB; Mamounas EP
    Ann Surg Oncol; 2012 Oct; 19(10):3139-43. PubMed ID: 22872291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse.
    Haffty BG; Reiss M; Beinfield M; Fischer D; Ward B; McKhann C
    J Clin Oncol; 1996 Jan; 14(1):52-7. PubMed ID: 8558220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care.
    Temple LK; Wang EE; McLeod RS
    CMAJ; 1999 Oct; 161(8):1001-8. PubMed ID: 10551200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Mortality with Repeat Lumpectomy Alone After Ipsilateral Breast Tumor Recurrence.
    Su Y; Guo R; Xue J; Chi Y; Chi W; Wang J; Yang B; Wu J
    Oncologist; 2019 Sep; 24(9):e818-e827. PubMed ID: 30842240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Course and Predictors of Subsequent Recurrence and Survival of Patients With Ipsilateral Breast Tumor Recurrence.
    Baek SY; Kim J; Chung IY; Ko BS; Kim HJ; Lee JW; Son BH; Ahn SH; Lee SB
    Cancer Control; 2022; 29():10732748221089412. PubMed ID: 35414226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncontrolled local disease after salvage treatment for ipsilateral breast tumour recurrence.
    Dalberg K; Liedberg A; Johansson U; Rutqvist LE
    Eur J Surg Oncol; 2003 Mar; 29(2):143-54. PubMed ID: 12633557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifocality in ipsilateral breast tumor recurrence - A study in ablative specimens.
    Walstra CJEF; Schipper RJ; Poodt IGM; Maaskant-Braat AJG; Luiten EJT; Vrancken Peeters MTFD; Smidt ML; Degreef E; Voogd AC; Nieuwenhuijzen GAP
    Eur J Surg Oncol; 2020 Aug; 46(8):1471-1476. PubMed ID: 32402507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial.
    Vrieling C; van Werkhoven E; Maingon P; Poortmans P; Weltens C; Fourquet A; Schinagl D; Oei B; Rodenhuis CC; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan DA; Dubois JB; Remouchamps V; Mirimanoff RO; Hart G; Collette S; Collette L; Bartelink H;
    JAMA Oncol; 2017 Jan; 3(1):42-48. PubMed ID: 27607734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Clinical Breast Examinations in Detecting Local-Regional Breast Events After Breast-Conservation in Women with a Personal History of High-Risk Breast Cancer.
    Neuman HB; Schumacher JR; Francescatti AB; Adesoye T; Edge SB; Burnside ES; Vanness DJ; Yu M; Si Y; McKellar D; Winchester DP; Greenberg CC
    Ann Surg Oncol; 2016 Oct; 23(10):3385-91. PubMed ID: 27491784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.